Primary Subretinal Seeding in Retinoblastoma: Clinical Presentation and Treatment Outcomes [0.03%]
视网膜母细胞瘤原发性亚视网膜种植的临床表现与治疗结果
Komal Bakal,Vishal Raval,Sai Krishna Gattu et al.
Komal Bakal et al.
Introduction: The aim of this study was to describe the clinical features and treatment outcomes of primary subretinal seeding (SRS) in patients with intraocular retinoblastoma (RB). ...
Ultrasound Verification of Plaque Brachytherapy Placement in Patients Treated for Primary Uveal Melanoma: A Single-Center Experience [0.03%]
原发性脉络膜黑色素瘤患者斑块近距离放射治疗定位的超声波验证：单中心经验
Joseph M Grimes,Henry Zhou,Alexis K Dal Col et al.
Joseph M Grimes et al.
Introduction: Proper plaque positioning is essential for effective episcleral plaque brachytherapy and can be verified using ultrasound. In this study, we show our center's protocol for intraoperative ultrasound verificat...
Orbital Complications and Cost Analysis of Enucleation by Myoconjunctival versus Conventional Techniques for Retinoblastoma [0.03%]
眼筋膜 Conjuctival 和传统方法治疗视网膜母细胞瘤的并发症和费用分析
Leonardo Lando,Ashwin Mallipatna,Stephanie N Kletke et al.
Leonardo Lando et al.
Introduction: The aim of the study was to compare complication rates and hospital costs of myoconjunctival versus conventional enucleation techniques in retinoblastoma. ...
Zackery Oakey,Yağmur Seda Yeşiltaş,Arun D Singh
Zackery Oakey
Background: Radiation optic neuropathy may be one side effect of ionizing radiation exposure to the eye found in a minority of patients. It is generally devastating for visual function and has been the subject of a small ...
When Is the Optimum Radiological Response to Proton Beam Therapy in Uveal Melanoma? [0.03%]
proton beam治疗葡萄膜黑色素瘤的最佳影像学反应时间是何时？
Matthew Gillam,Glenn Ace Fenech,Oliver Chadwick et al.
Matthew Gillam et al.
Introduction: Proton beam therapy (PBT) is an effective treatment option for uveal melanomas. Following treatment, it may take many months for the tumour to respond and it may initially enlarge. We reviewed our PBT patien...
Clinical, Radiological, and Histopathological Findings of Post-Exenterated Mucormycosis Specimens [0.03%]
术后曲霉病标本的临床、放射和病理组织学特征
Vidhyadevi Ramasamy,Shiguru Saudhamini,Sakhtisankari Shanmugasundaram et al.
Vidhyadevi Ramasamy et al.
Introduction: A sharp upsurge in the number of coronavirus disease-associated mucormycosis cases was noted during the second wave of coronavirus disease in India. The fungal hyphae spread from the nasal mucosa, orbit to t...
Predictive Value of the International Classification of Diseases, 9th Revision Codes for Identifying Ocular Oncology Diagnoses [0.03%]
国际疾病分类第九修订本(ICD-9)编码识别眼部肿瘤的预测价值
Kenny Y Wang,Timothy T Xu,Launia J White et al.
Kenny Y Wang et al.
Introduction: The aim of this study was to determine the predictive value of International Classification of Diseases, 9th Revision (ICD-9) billing codes for identifying ocular oncology diagnoses. ...
Outcomes after Proton Beam Irradiation in Patients with Choroidal Melanoma Eligible for Investigational AU-011 Treatment [0.03%]
适合接受AU-011治疗的脉络膜黑色素瘤患者质子束放疗后的预后效果研究
Frances Wu,Anne Marie Lane,Alexei Trofimov et al.
Frances Wu et al.
Introduction: Vision loss is common in patients treated with radiotherapy for uveal melanoma. With proton beam irradiation (PBI), the prescribed dose is delivered to the tumor with a sharp dose reduction outside the targe...
Sympathetic Ophthalmia in Patients with Enucleation or Evisceration: Pathology Laboratory and IRIS® Registry Experience [0.03%]
眼球摘除或眼内容物剜出术患者交感性眼炎的病理和IRIS数据库经验
Khanh Bui,Maurizio Tomaiuolo,Kaylene Carter et al.
Khanh Bui et al.
Introduction: Sympathetic ophthalmia (SO) is a rare bilateral granulomatous panuveitis that can follow surgical or nonsurgical ocular trauma in one eye. Because its diagnosis requires clinical-pathologic correlation, the ...
Subconjunctival Ocular Argyrosis following Treatment with Ruthenium 106 Brachytherapy for Choroidal Melanoma [0.03%]
ruthenium-106敷贴治疗脉络膜黑色素瘤后发生的结膜下蓝染沉着症
Aya Khasati,Caroline Thaung,Hardeep S Mudhar et al.
Aya Khasati et al.
Introduction: Ruthenium-106 (Ru-106) brachytherapy is one of the commonest eye-sparing treatments for choroidal melanoma. These patients require long-term surveillance of the treated tumour remnant to ensure there is no l...